Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Respiratory Medicine

Journal Scan / Research · August 31, 2023

Impact of Systemic Sclerosis–Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival

Chest

 

Additional Info

Disclosure statements are available on the authors' profiles:

Chest
Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis
Chest 2023 Aug 13;[EPub Ahead of Print], P Moinzadeh, F Bonella, M Oberste, J Weliwitage, N Blank, G Riemekasten, U Müller-Ladner, J Henes, E Siegert, C Günther, I Kötter, C Pfeiffer, M Schmalzing, G Zeidler, P Korsten, L Susok, A Juche, M Worm, I Jandova, J Ehrchen, C Sunderkötter, G Keyßer, A Ramming, T Schmeiser, A Kreuter, HM Lorenz, N Hunzelmann, M Kreuter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading